(Q44093898)

29 November 2017

title

Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways (English)

1 reference

29 November 2017

1 reference

Makoto Nishizawa

1

1 reference

29 November 2017

Hajime Nakabayashi

2

1 reference

29 November 2017

Keigo Uehara

3

1 reference

29 November 2017

Atsushi Nakagawa

4

1 reference

29 November 2017

Kenzo Uchida

5

1 reference

29 November 2017

Daisuke Koya

6

1 reference

29 November 2017

publication date

28 May 2013

1 reference

American Journal of Physiology - Endocrinology and Metabolism

29 November 2017

published in

1 reference

29 November 2017

volume

305

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

E376-87

1 reference

Autonomic regulation of islet hormone secretion--implications for health and disease

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Functional and chemical anatomy of the afferent vagal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

“What Is Inherited – What Is Added” Hypothesis for the Pathogenesis of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Portal vein glucose entry triggers a coordinated cellular response that potentiates hepatic glucose uptake and storage in normal but not high-fat/high-fructose-fed dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

The incretin concept today

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

The incretin system and its role in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Direct effect of CNS on insulin hypersecretion in obese Zucker rats: involvement of vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

The hepatic vagus nerve and the neural regulation of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Important role of the hepatic vagus nerve in glucose uptake and production by the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Neurons with access to the general circulation in the central nervous system of the rat: A retrograde tracing study with fluoro-gold

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Pancreatic Neuroendocrinology: Peripheral Neural Mechanisms in the Regulation of the Islets of Langerhans*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Glucose-sensitive afferent nerve fibres in the hepatic branch of the vagus nerve in the guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

The fiber composition of the abdominal vagus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Vagal neurons and pathways to the rat's lower viscera: an electrophysiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Neural control of the endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Pancreatic vagal functional distribution in the secretion of insulin evoked by portal infusion of D-glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00565.2012

10.1152/AJPENDO.00565.2012

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference